dc.contributor.author | ZEYBEK, Umit | |
dc.contributor.author | Kemerdere, Rahşan | |
dc.contributor.author | Kaynar, Mehmet Yaşar | |
dc.contributor.author | YAYLIM, İlhan | |
dc.contributor.author | KÜÇÜKHÜSEYİN, Özlem | |
dc.contributor.author | KAFADAR, Ali | |
dc.contributor.author | TURAN, Saime | |
dc.contributor.author | YENILMEZ, Ezgi Nurdan | |
dc.contributor.author | TUNOGLU, Servet | |
dc.date.accessioned | 2021-03-05T07:14:31Z | |
dc.date.available | 2021-03-05T07:14:31Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | KAFADAR A., KÜÇÜKHÜSEYİN Ö., TURAN S., YENILMEZ E. N. , TUNOGLU S., ZEYBEK U., Kaynar M. Y. , Kemerdere R., YAYLIM İ., "Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.", Anticancer research, cilt.35, ss.3933-42, 2015 | |
dc.identifier.issn | 0250-7005 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_92c312ba-3e44-4f93-970d-73b934771ae0 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/98960 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84937143848&origin=inward | |
dc.language.iso | eng | |
dc.title | Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors. | |
dc.type | Makale | |
dc.relation.journal | Anticancer research | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 35 | |
dc.identifier.issue | 7 | |
dc.identifier.startpage | 3933 | |
dc.identifier.endpage | 42 | |
dc.contributor.firstauthorID | 112064 | |